NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新)

2021-06-14 英国国家卫生与临床优化研究所 NICE官网

本指南涵盖了 18 岁及以上人群疑似或确诊的自闭症谱系障碍(自闭症、阿斯伯格综合症和非典型自闭症)的诊断和管理。它旨在改善自闭症患者对干预和服务的获取和参与,以及护理体验。

中文标题:

NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新)

英文标题:

Autism spectrum disorder in adults: diagnosis and management(Last updated: 14 June 2021)

发布日期:

2021-06-14

简要介绍:

本指南涵盖了 18 岁及以上人群疑似或确诊的自闭症谱系障碍(自闭症、阿斯伯格综合症和非典型自闭症)的诊断和管理。它旨在改善自闭症患者对干预和服务的获取和参与,以及护理体验。

2021 年 6 月:NICE修改了关于识别和评估的建议,以澄清当使用自闭症谱商 - 10 项 (AQ-10) 评估可能的自闭症时,应为该人提供综合评估的分数为 6或以上。

相关资料下载:
[AttachmentFileName(sort=1, fileName=NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新).pdf)] GetToolGuiderByIdResponse(projectId=1, id=f9b461c0022621c2, title=NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新), enTitle=Autism spectrum disorder in adults: diagnosis and management(Last updated: 14 June 2021), guiderFrom=NICE官网, authorId=0, author=, summary=本指南涵盖了 18 岁及以上人群疑似或确诊的自闭症谱系障碍(自闭症、阿斯伯格综合症和非典型自闭症)的诊断和管理。它旨在改善自闭症患者对干预和服务的获取和参与,以及护理体验。, cover=https://img.medsci.cn/20211114/1636857478374_1608702.jpg, journalId=0, articlesId=null, associationId=85, associationName=英国国家卫生与临床优化研究所, associationIntro=英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence)是NHS的组织,设在伦敦和曼彻斯特。NICE成立于1999年4月1日,目标是确保每个英格兰和威尔士人平等享有NHS医疗的机会。NICE制定指南,设定质量标准,管理国家数据库,为NHS、当地权威部门和其他组织提供指南。, copyright=0, guiderPublishedTime=Mon Jun 14 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p class="lead" style="color: #0e0e0e;">本指南涵盖了 18 岁及以上人群疑似或确诊的自闭症谱系障碍(自闭症、阿斯伯格综合症和非典型自闭症)的诊断和管理。它旨在改善自闭症患者对干预和服务的获取和参与,以及护理体验。</p> <p style="color: #0e0e0e;"><strong>2021 年 6 月:</strong>NICE修改了关于识别和评估的建议,以澄清当使用自闭症谱商 - 10 项 (AQ-10) 评估可能的自闭症时,应为该人提供综合评估的分数为 6或以上。</p>, tagList=[TagDto(tagId=117608, tagName=咨询与治疗), TagDto(tagId=117610, tagName=成人自闭症谱系障碍)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=10466, guiderKeyword=自闭症谱系障碍, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2750, appHits=133, showAppHits=0, pcHits=660, showPcHits=2617, likes=14, shares=5, comments=6, approvalStatus=1, publishedTime=Tue Nov 16 23:57:56 CST 2021, publishedTimeString=2021-06-14, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=dajiong, createdTime=Sun Nov 14 11:04:52 CST 2021, updatedBy=4754896, updatedName=小小医者, updatedTime=Sat Jan 06 05:09:56 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新).pdf)])
NICE临床指南:成人自闭症谱系障碍的诊断和管理(2021更新).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099830, encodeId=fd1920998304a, content=很重要啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:39:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210539, encodeId=f11b121053962, content=学习🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220412/352c3a782e7c4003bca9deb73de8e680/879501ea58b2474c82040244e8513059.jpg, createdBy=ffff5459630, createdName=ms4000000616902662, createdTime=Tue Apr 12 12:28:33 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184715, encodeId=e3db1184e1579, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:54:34 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070703, encodeId=20e910e070332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Tue Nov 16 10:40:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-11-11 ozzy

    很重要啊

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099830, encodeId=fd1920998304a, content=很重要啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:39:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210539, encodeId=f11b121053962, content=学习🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220412/352c3a782e7c4003bca9deb73de8e680/879501ea58b2474c82040244e8513059.jpg, createdBy=ffff5459630, createdName=ms4000000616902662, createdTime=Tue Apr 12 12:28:33 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184715, encodeId=e3db1184e1579, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:54:34 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070703, encodeId=20e910e070332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Tue Nov 16 10:40:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-04-12 ms4000000616902662

    学习🙏

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099830, encodeId=fd1920998304a, content=很重要啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:39:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210539, encodeId=f11b121053962, content=学习🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220412/352c3a782e7c4003bca9deb73de8e680/879501ea58b2474c82040244e8513059.jpg, createdBy=ffff5459630, createdName=ms4000000616902662, createdTime=Tue Apr 12 12:28:33 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184715, encodeId=e3db1184e1579, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:54:34 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070703, encodeId=20e910e070332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Tue Nov 16 10:40:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2022-01-15 1e22b426m70(暂无匿称)

    值得学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099830, encodeId=fd1920998304a, content=很重要啊, beContent=null, objectType=guider, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Fri Nov 11 10:39:28 CST 2022, time=2022-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1210539, encodeId=f11b121053962, content=学习🙏, beContent=null, objectType=guider, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220412/352c3a782e7c4003bca9deb73de8e680/879501ea58b2474c82040244e8513059.jpg, createdBy=ffff5459630, createdName=ms4000000616902662, createdTime=Tue Apr 12 12:28:33 CST 2022, time=2022-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1184715, encodeId=e3db1184e1579, content=值得学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220116/72e91e7990f7455db4693ee7aeff8937/30cd494ac4214e05b38c2d6fadfa8410.jpg, createdBy=43bf2028192, createdName=1e22b426m70(暂无匿称), createdTime=Sat Jan 15 23:54:34 CST 2022, time=2022-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070703, encodeId=20e910e070332, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a64817967, createdName=m18643d5f53m, createdTime=Tue Nov 16 10:40:15 CST 2021, time=2021-11-16, status=1, ipAttribution=)]
    2021-11-16 m18643d5f53m

    学习

    0

拓展阅读

2019 IPS临床实践指南:自闭症谱系障碍

国外精神科相关专家小组(统称) · 2019-01-20

2019 CPS立场声明:自闭症谱系障碍的诊断评估标准

加拿大儿科学会(CPS,Canadian Paediatric Society) · 2019-11-01

2020 AAN实践指南:自闭症谱系障碍儿童和青少年失眠和睡眠行为紊乱的治疗

美国神经病学学会(AAN,American Academy of Neurology) · 2020-02-12

2020 AAP临床报告:儿童自闭症谱系障碍的识别,评估和管理

美国儿科学会(AAP,American Academy of Pediatrics) · 2020-01-20

患有 ADHD 的 ASD 与单独的 ASD 和 ADHD:儿童和青少年 QbTest 性能和单剂量哌醋甲酯反应的研究

吉尔伯格神经精神病学中心 Gillberg Neuropsychiatry Centre · 2022-04-20